The parametric g‐formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death

The parametric g‐formula can be used to contrast the distribution of potential outcomes under arbitrary treatment regimes. Like g‐estimation of structural nested models and inverse probability weighting of marginal structural models, the parametric g‐formula can appropriately adjust for measured time‐varying confounders that are affected by prior treatment. However, there have been few implementations of the parametric g‐formula to date. Here, we apply the parametric g‐formula to assess the impact of highly active antiretroviral therapy on time to acquired immune deficiency syndrome (AIDS) or death in two US‐based human immunodeficiency virus cohorts including 1498 participants. These participants contributed approximately 7300 person‐years of follow‐up (49% exposed to highly active antiretroviral therapy) during which 382 events occurred and 259 participants were censored because of dropout. Using the parametric g‐formula, we estimated that antiretroviral therapy substantially reduces the hazard of AIDS or death (hazard ratio = 0.55; 95% confidence limits [CL]: 0.42, 0.71). This estimate was similar to one previously reported using a marginal structural model, 0.54 (95% CL: 0.38, 0.78). The 6.5‐year difference in risk of AIDS or death was 13% (95% CL: 8%, 18%). Results were robust to assumptions about temporal ordering, and extent of history modeled, for time‐varying covariates. The parametric g‐formula is a viable alternative to inverse probability weighting of marginal structural models and g‐estimation of structural nested models for the analysis of complex longitudinal data. Copyright © 2012 John Wiley & Sons, Ltd.

[1]  J. Robins A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .

[2]  J. Robins A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. , 1987, Journal of chronic diseases.

[3]  J. Phair,et al.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.

[4]  J. Robins The control of confounding by intermediate variables. , 1989, Statistics in medicine.

[5]  M A Fischl,et al.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. , 1997, The New England journal of medicine.

[6]  Joseph Feldman,et al.  The Women's Interagency HIV Study , 1998 .

[7]  C Maurath,et al.  Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. , 1998, Lancet.

[8]  L. Kalish,et al.  The Women's Interagency HIV Study. WIHS Collaborative Study Group. , 1998, Epidemiology.

[9]  Calvin Cohen,et al.  Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease , 1998, The Lancet.

[10]  J. Robins,et al.  Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.

[11]  J. Robins,et al.  Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. , 2003, American journal of epidemiology.

[12]  M. Davidian,et al.  Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology. , 2004, American journal of epidemiology.

[13]  J. Robins,et al.  A Structural Approach to Selection Bias , 2004, Epidemiology.

[14]  Uwe Siebert,et al.  Effects of multiple interventions , 2004 .

[15]  Jonathan AC Sterne,et al.  Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study , 2005, The Lancet.

[16]  J. Robins,et al.  Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/pds.1064 , 2022 .

[17]  James M Robins,et al.  Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. , 2005, American journal of epidemiology.

[18]  J. Robins,et al.  Estimating causal effects from epidemiological data , 2006, Journal of Epidemiology and Community Health.

[19]  J. Robins,et al.  Comparison of dynamic treatment regimes via inverse probability weighting. , 2006, Basic & clinical pharmacology & toxicology.

[20]  James M Robins,et al.  Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. , 2007, American journal of epidemiology.

[21]  Mark J van der Laan,et al.  Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification , 2008, AIDS.

[22]  M. Robins James,et al.  Estimation of the causal effects of time-varying exposures , 2008 .

[23]  S. Cole,et al.  Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence , 2008, AIDS.

[24]  R. Geskus,et al.  A simple G‐computation algorithm to quantify the causal effect of a secondary illness on the progression of a chronic disease , 2009, Statistics in Medicine.

[25]  Stephen R Cole,et al.  The consistency statement in causal inference: a definition or an assumption? , 2009, Epidemiology.

[26]  J. Robins,et al.  Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. , 2009, International journal of epidemiology.

[27]  James M Robins,et al.  Estimating Absolute Risks in the Presence of Nonadherence: An Application to a Follow-up Study With Baseline Randomization , 2010, Epidemiology.

[28]  S. Cole,et al.  Invited commentary: positivity in practice. , 2010, American journal of epidemiology.

[29]  Daniel Almirall,et al.  Structural Nested Mean Models for Assessing Time‐Varying Effect Moderation , 2010, Biometrics.

[30]  S. Cole,et al.  Illustrating bias due to conditioning on a collider. , 2010, International journal of epidemiology.

[31]  James M. Robins,et al.  Comparative Effectiveness of Dynamic Treatment Regimes: An Application of the Parametric G-Formula , 2011, Statistics in biosciences.

[32]  Sherri Rose,et al.  Implementation of G-computation on a simulated data set: demonstration of a causal inference technique. , 2011, American journal of epidemiology.

[33]  J. Robins Structural Nested Failure Time Models , 2005 .